Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 55 min ago
Peer-reviewedCC BYEuropean journal of pediatrics

Blood sampling for research purposes in children: a practical guide to volume limits and minimisation strategies.

  • Janez Jazbec1,2
  • Barbara Faganel Kotnik3,4
  • Tomaž Prelog3
  • Marko Pokorn4,5
5 affiliations
  1. 1Department of Paediatric Haematology and Oncology, University Medical Centre Ljubljana, University Children's Hospital, Ljubljana, Slovenia. [email protected].
  2. 2Faculty of Medicine, Department of Paediatrics, University of Ljubljana, Ljubljana, Slovenia. [email protected].
  3. 3Department of Paediatric Haematology and Oncology, University Medical Centre Ljubljana, University Children's Hospital, Ljubljana, Slovenia.
  4. 4Faculty of Medicine, Department of Paediatrics, University of Ljubljana, Ljubljana, Slovenia.
  5. 5University Medical Centre Ljubljana, University Children's Hospital, Ljubljana, Slovenia.
Read full textPDFDOICite

Abstract

Blood sampling performed only for research purposes usually offers no direct benefit to the child, and children's limited total blood volume and susceptibility to anaemia call for a cautious, standardised approach. This review summarises published recommendations on blood sampling volumes for research purposes in children and translates them into practical guidance for protocol design and everyday research practice. Guidance from WHO, the European Commission, PedCRIN and ICH documents was synthesised together with current empirical literature on the safety of blood sampling and on volume-minimisation techniques in paediatric studies. Published recommendations are heterogeneous and rest on limited evidence. European recommendations propose that research-related blood loss should as a general rule not exceed 1% of total blood volume (TBV) at any single time point and 3% of TBV over 4 weeks. We present these as reference values in a weight-based table, applied over a rolling 4-week window. In children with clinically significant anaemia, research-only sampling should be deferred or individually justified. Residual diagnostic samples, small-volume collection tubes, sparse sampling with population pharmacokinetic modelling, and volumetric microsampling (VAMS/DBS) substantially reduce blood burden, although microsampling has analytical limitations. Practical tracking of cumulative blood volume and coordination between teams are described. Parental informed consent must be complemented by the child's assent, sought according to age and maturity and checked during the study.Conclusion

These reference values and minimisation strategies offer a practical starting point for protocol design and ethics review. They are not proof of safety and need individual adjustment in sick children.What is known

• Published recommendations on research blood sampling in children are heterogeneous; European recommendations propose ≤ 1% of total blood volume at a single time point and ≤ 3% over 4 weeks. • Evidence supporting these thresholds is limited.What is new

• This review translates these recommendations into a practical framework: a weight-based reference table, rolling 4-week tracking of research blood loss alongside clinical sampling, and coordination between clinical and research teams. • It summarises residual-sample and microsampling strategies, including their limitations.

Related

  1. Vascular access options for complex high-risk indicated percutaneous coronary interventions: contemporary strategies, trade-offs, and practical algorithms
    Giuseppe Colletti, Chadi Ghafari, Zoltan Ruzsa +12
    Frontiers in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  2. Systemic Therapies in Advanced Adrenocortical Carcinoma: Current Standards, Emerging Strategies, and Practical Considerations
    Lina Pedraza Sanchez, Prerna Dogra, Elio Monsour +1
    CancersPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossrefEurope PMC
  3. Research progress and practical applications of musculoskeletal ultrasound in military training injuries
    Shuo Wang, Hanhan Xu, Qianqian Liu +2
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Engaging children, adolescents and young adults living with rare diseases as research partners: practical considerations for meaningful involvement
    Maria Cavaller-Belaubi, Elena-Alexandra Tataru, Donato Bonifazi +11
    Frontiers in pediatricsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Navigating HPV vaccination challenges in low-resource settings: Practical strategies for estimating the size of out-of-school girls
    Soim Park, Erica N Rosser, Leanne Zhang +6
    PLOS OnePeer-reviewedCC BYFull textImmunologyMicrobiologyPLOSEurope PMC

Cite

BibTeXRIS
BibTeX
@article{jazbec2026blood,
  title = {{Blood sampling for research purposes in children: a practical guide to volume limits and minimisation strategies.}},
  author = {Janez Jazbec and Barbara Faganel Kotnik and Tomaž Prelog and Marko Pokorn},
  journal = {European journal of pediatrics},
  year = {2026},
  month = oct,
  doi = {10.1007/s00431-026-07583-1},
  url = {https://europepmc.org/article/MED/42955394},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Blood sampling for research purposes in children: a practical guide to volume limits and minimisation strategies.
AU  - Janez Jazbec
AU  - Barbara Faganel Kotnik
AU  - Tomaž Prelog
AU  - Marko Pokorn
PY  - 2026
DA  - 2026/10/29
JO  - European journal of pediatrics
DO  - 10.1007/s00431-026-07583-1
UR  - https://europepmc.org/article/MED/42955394
AB  - Blood sampling performed only for research purposes usually offers no direct benefit to the child, and children's limited total blood volume and susceptibility to anaemia call for a cautious, standardised approach. This review summarises published recommendations on blood sampling volumes for research purposes in children and translates them into practical guidance for protocol design and everyday research practice. Guidance from WHO, the European Commission, PedCRIN and ICH documents was synthesised together with current empirical literature on the safety of blood sampling and on volume-minimisation techniques in paediatric studies. Published recommendations are heterogeneous and rest on limited evidence. European recommendations propose that research-related blood loss should as a general rule not exceed 1% of total blood volume (TBV) at any single time point and 3% of TBV over 4 weeks. We present these as reference values in a weight-based table, applied over a rolling 4-week window. In children with clinically significant anaemia, research-only sampling should be deferred or individually justified. Residual diagnostic samples, small-volume collection tubes, sparse sampling with population pharmacokinetic modelling, and volumetric microsampling (VAMS/DBS) substantially reduce blood burden, although microsampling has analytical limitations. Practical tracking of cumulative blood volume and coordination between teams are described. Parental informed consent must be complemented by the child's assent, sought according to age and maturity and checked during the study.Conclusion  These reference values and minimisation strategies offer a practical starting point for protocol design and ethics review. They are not proof of safety and need individual adjustment in sick children.What is known  • Published recommendations on research blood sampling in children are heterogeneous; European recommendations propose ≤ 1% of total blood volume at a single time point and ≤ 3% over 4 weeks. • Evidence supporting these thresholds is limited.What is new  • This review translates these recommendations into a practical framework: a weight-based reference table, rolling 4-week tracking of research blood loss alongside clinical sampling, and coordination between clinical and research teams. • It summarises residual-sample and microsampling strategies, including their limitations.
SN  - 0340-6199
SN  - 1432-1076
ER  -